Skip to main content
Log in

Aberrant sexual behaviours in Parkinson’s disease during dopaminergic treatment

  • LETTER TO THE EDITORS
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Berger Ch, Mehrhoff FW, Beier KM, Meinck HM (2003) Sexual delinquency and Parkinson’s disease. Nervenarzt 74(4): 370–375

    Article  PubMed  Google Scholar 

  2. Cummings JL (1991) Behavioral complications of drug treatment of Parkinson’s disease. J Am Geriatr Soc 39(7): 708–716

    PubMed  CAS  Google Scholar 

  3. Fahn S, Elton RL, members of the UPDRS Development Committee (1987) The Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, et al. (eds). Recent developments in Parkinson’s disease. Flotham Park, NJ: Macmillan Healthcare Information, pp 153–163

    Google Scholar 

  4. Fernandez HH, Durso R (1998) Clozapine for dopaminergic-induced paraphilias in Parkinson’s disease. Mov Disord 13(3): 597–598

    Article  PubMed  CAS  Google Scholar 

  5. Folstein MF, Folstein SE, McHugh PR (1995) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3): 189–198

    Article  Google Scholar 

  6. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17(5): 427–442

    PubMed  CAS  Google Scholar 

  7. Hughes AJ, Ben-Shlomo SE, Daniels SE, Lees AJ (1992) What features improve the accuracy of clinical diagnosis in Parkinson’s disease? Neurology 42: 1142–1146

    PubMed  CAS  Google Scholar 

  8. Jimenez-Jimenez FJ, Sayed Y, Garcia-Soldevilla MA, Barcenilla B (2002) Possible zoophilia associated with dopaminergic therapy in Parkinson disease. Ann Pharmacother 36(7–8): 1178–1179

    Article  PubMed  Google Scholar 

  9. Jimenez-Jimenez FJ, Tallon-Barranco A, Cabrera-Valdivia F, Gasalla T, Orti-Pareja M, Zurdo M (1999) Fluctuating penile erection related with levodopa therapy. Neurology 52(1): 210

    PubMed  CAS  Google Scholar 

  10. Quinn NP, Toone B, Lang AE, Marsden CD, Parkes JD (1983) Dopa dose-dependent sexual deviation. Br J Psychiatry 142: 296–298

    Article  PubMed  CAS  Google Scholar 

  11. Kanovsky P, Bares M, Pohanka M, Rektor I (2002) Penile erections and hypersexuality induced by pergolide treatment in advanced, fluctuating Parkinson’s disease. J Neurol 249(1): 112–114

    Article  PubMed  Google Scholar 

  12. Molina JA, Sainz-Artiga MJ, Fraile A, Jimenez-Jimenez FJ, Villanueva C, Orti-Pareja M, Bermejo F (2000) Pathologic gambling in Parkinson’s disease: a behavioral manifestation of pharmacologic treatment? Mov Disord 15(5): 869–872

    Article  PubMed  CAS  Google Scholar 

  13. Reisberg B, Ferris SH, de Leon MJ, Crook T (1982) The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 139(9): 1136–1139

    PubMed  CAS  Google Scholar 

  14. Riley DE (2002) Reversible transvestic fetishism in a man with Parkinson’s disease treated with selegiline. Clin Neuropharmacol 25(4): 234–237

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The Authors thank Prof. Gian Luigi Gessa for his kind advice and assistance in preparation of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paolo Solla.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cannas, A., Solla, P., Floris, G.L. et al. Aberrant sexual behaviours in Parkinson’s disease during dopaminergic treatment. J Neurol 254, 110–112 (2007). https://doi.org/10.1007/s00415-006-0285-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-006-0285-x

Keywords

Navigation